We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTT
3626
DELISTED
GTT Communications, Inc.
GTT
| $270K | ﹤0.01% |
28,642
-3,710
| -11% | -$41.7K |
|
3627
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
| $269K | ﹤0.01% |
19,973
| – | – |
|
3628
Daktronics
DAKT
$955M
| $267K | ﹤0.01% |
36,114
+2,008
| +6% | +$13.4K |
|
3629
Repay Holdings
RPAY
$331M
| $267K | ﹤0.01% |
+20,000
| New | +$244K |
|
3630
United Microelectronic
UMC
$47.7B
| $267K | ﹤0.01% |
+127,815
| New | +$273K |
|
3631
PUT
Altria Group
MO
$114B
| $266K | ﹤0.01% |
6,500
-354,000
| -98% | -$16.3M |
|
3632
Unisys
UIS
$209M
| $266K | ﹤0.01% |
35,794
+3,904
| +12% | +$34.7K |
|
3633
ASE Group
ASX
$77.3B
| $265K | ﹤0.01% |
+59,327
| New | +$261K |
|
3634
e.l.f. Beauty
ELF
$4.89B
| $264K | ﹤0.01% |
15,056
+2,517
| +20% | +$42K |
|
3635
CALL
Visteon
VC
$2.79B
| $264K | ﹤0.01% |
+3,200
| New | +$214K |
|
|
SOHU
3636
Sohu.com
SOHU
$362M
| $262K | ﹤0.01% |
25,773
-42
| -0.2% | -$494 |
|
|
SEI
3637
Solaris Energy Infrastructure
SEI
$3.15B
| $262K | ﹤0.01% |
19,563
+23
| +0.1% | +$314 |
|
|
LL
3638
DELISTED
LL Flooring Holdings, Inc.
LL
| $261K | ﹤0.01% |
26,429
-10,854
| -29% | -$106K |
|
|
LDL
3639
DELISTED
Lydall, Inc.
LDL
| $261K | ﹤0.01% |
+10,520
| New | +$225K |
|
|
AABA
3640
CALL
DELISTED
Altaba Inc
AABA
| $261K | ﹤0.01% |
13,400
-4,200
| -24% | -$278K |
|
3641
CALL
Logitech
LOGI
$14.7B
| $257K | ﹤0.01% |
6,300
-43,700
| -87% | -$1.76M |
|
3642
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $257K | ﹤0.01% |
+4,497
| New | +$254K |
|
|
GDEN
3643
DELISTED
Golden Entertainment
GDEN
| $256K | ﹤0.01% |
19,340
+731
| +4% | +$10.2K |
|
|
WTRE
3644
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $256K | ﹤0.01% |
+9,506
| New | +$232K |
|
3645
Astrana Health
ASTH
$1.76B
| $255K | ﹤0.01% |
14,434
+2,485
| +21% | +$42.5K |
|
|
CHUY
3646
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $255K | ﹤0.01% |
10,285
-1,267
| -11% | -$30.6K |
|
3647
Anterix
ATEX
$1.81B
| $254K | ﹤0.01% |
7,030
+2,289
| +48% | +$96.5K |
|
3648
Golar LNG
GLNG
$5B
| $254K | ﹤0.01% |
19,591
-6,662
| -25% | -$97.9K |
|
|
HDV
3649
iShares Core High Dividend ETF
HDV
$14.5B
| $254K | ﹤0.01% |
13,500
-32,450
| -71% | -$610K |
|
|
GNMK
3650
DELISTED
GenMark Diagnostics, Inc
GNMK
| $253K | ﹤0.01% |
41,792
+2,852
| +7% | +$17.8K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.